Abstract
We report the optimisation of a series of novel amide-piperidine (piperazine) derivatives using the multiple ligand approach with dopamine and serotonin receptors. Of the derivatives, compound 11 exhibited high affinity for the D2, 5-HT1A, and 5-HT2A receptors, but low affinity for the 5-HT2C and histamine H1 receptors and human ether-a-go-go-related gene (hERG) channels. In vivo, compound 11 reduced apomorphine-induced climbing, MK-801-induced hyperactivity and DOI-induced head twitching without observable catalepsy, even at the highest dose tested. In addition, it exhibited suppression in a CAR test. Furthermore, in a novel object recognition task, it displayed procognition properties. Therefore, compound 11 is a promising candidate multi-target antipsychotic.
Keywords:
Amide; Antipsychotic; Multi-target; Piperazine; Piperidine.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amides / chemical synthesis
-
Amides / chemistry
-
Amides / pharmacology*
-
Animals
-
Antipsychotic Agents / chemical synthesis
-
Antipsychotic Agents / chemistry
-
Antipsychotic Agents / pharmacology*
-
Dose-Response Relationship, Drug
-
Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
-
Ether-A-Go-Go Potassium Channels / metabolism
-
Humans
-
Ligands
-
Molecular Structure
-
Piperazine / chemical synthesis
-
Piperazine / chemistry
-
Piperazine / pharmacology*
-
Piperidines / chemical synthesis
-
Piperidines / chemistry
-
Piperidines / pharmacology*
-
Rats
-
Receptors, Dopamine D2 / metabolism
-
Receptors, Serotonin / metabolism
-
Schizophrenia / drug therapy*
-
Schizophrenia / metabolism
-
Structure-Activity Relationship
Substances
-
Amides
-
Antipsychotic Agents
-
Ether-A-Go-Go Potassium Channels
-
Ligands
-
Piperidines
-
Receptors, Dopamine D2
-
Receptors, Serotonin
-
Piperazine
-
piperidine